奕瑞科技(688301) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥481,505,741.56, a decrease of 1.92% compared to ¥490,911,525.92 in the same period last year[3] - Net profit attributable to shareholders was ¥143,110,620.86, representing an increase of 2.74% from ¥139,287,790.89 year-on-year[3] - The net profit excluding non-recurring gains and losses was ¥141,283,030.00, down 9.19% from ¥155,573,268.23 in the previous year[3] - Total revenue for Q1 2025 was CNY 481,505,741.56, a decrease of 1.0% from CNY 490,911,525.92 in Q1 2024[17] - Net profit for Q1 2025 was CNY 135,644,940.70, a slight decrease of 1.1% compared to CNY 137,155,894.49 in Q1 2024[18] Earnings and Shares - The basic earnings per share for the period was ¥1.00, up 2.04% from ¥0.98 in the same period last year[3] - The diluted earnings per share was ¥0.96, an increase of 3.23% from ¥0.93 year-on-year[4] - Basic earnings per share for Q1 2025 was CNY 1.00, compared to CNY 0.98 in Q1 2024, reflecting a 2.0% increase[19] Cash Flow - The net cash flow from operating activities was ¥71,178,263.69, a significant improvement from a negative cash flow of ¥42,258,174.73 in the same period last year[3] - Cash flow from operating activities increased significantly to CNY 490,895,984.64 in Q1 2025, up from CNY 344,548,347.08 in Q1 2024, representing a growth of 42.5%[21] - Operating cash inflows totaled $529,645,436.12, compared to $408,229,535.41 in the prior period, showing a year-over-year increase of approximately 29.6%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,133,693,916.40, an increase of 0.56% from ¥9,083,006,463.92 at the end of the previous year[4] - Total liabilities decreased to CNY 4,350,977,177.40 from CNY 4,436,602,437.53, indicating a reduction of 1.9%[16] - The company's total equity increased to CNY 4,782,716,739.00 from CNY 4,646,404,026.39, reflecting a growth of 2.9%[16] Research and Development - Research and development expenses totaled ¥60,088,540.57, a decrease of 12.33% from ¥68,541,759.76 year-on-year, accounting for 12.48% of operating revenue[4] - Research and development expenses for Q1 2025 were CNY 60,088,540.57, down 12.3% from CNY 68,541,759.76 in Q1 2024[18] Government Subsidies - The company received government subsidies amounting to ¥3,145,454.18, which are closely related to its normal operations[6] Current Assets - The company reported a total current assets of approximately ¥3.86 billion as of March 31, 2025, a decrease of about 2.5% from ¥3.95 billion on December 31, 2024[14] - Cash and cash equivalents decreased to approximately ¥1.99 billion from ¥2.10 billion, reflecting a decline of about 5.5%[14] - Accounts receivable increased to approximately ¥769 million, up from ¥749 million, indicating a growth of about 2.5%[14] - Inventory remained relatively stable at approximately ¥794 million, slightly down from ¥798 million[14] Fixed Assets - The company’s fixed assets increased significantly to approximately ¥1.99 billion from ¥1.44 billion, representing a growth of about 38.4%[14] - The company holds long-term equity investments valued at approximately ¥72 million, unchanged from the previous period[14] - The company’s goodwill remained stable at approximately ¥87.78 million[14] - The total non-current assets were approximately ¥2.57 billion, reflecting a decrease from the previous period[14] Shareholder Information - The company has no significant changes in the top ten shareholders or their shareholding status[11] Strategic Developments - There are no significant new strategies or product developments mentioned in the conference call[12]